AKBA
Akebia Therapeutics, Inc.
$1.36
-12.58%
-0.20
Notify me if price changes either direction
Buy AKBA stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
360.9M
Enterprise value
443.9M
Trailing PE
-4.106060663859
Forward PE
26.93
PEG Ratio
0.04106060663859
Enterprise to EBITDA
13.765
Enterprise to revenue
1.972
Price to book MRQ
8.576433
Price to sales TTM
1.5875671
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
225.1M
EBITDA
32.2M
Diluted EPS TTM
-0.08
Total Cash (MRQ)
166.4M
Current ratio (MRQ)
1.937
Operating Cash Flow (TTM)
32.4M
AKBA trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
February 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
